Robert Charles Breedlove serves as Executive at Phathom Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Robert Charles Breedlove has executed 5 insider transactions totaling $26.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 21, 2026 involved selling 776 shares valued at $10.6K.
Robert Charles Breedlove currently holds 47,068 shares of Phathom Pharmaceuticals, Inc. (PHAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Charles Breedlove has been a net seller of PHAT stock. They have purchased $0 and sold $26.8K worth of shares.
Robert Charles Breedlove's most recent insider trade was on Jan 21, 2026, when they sold 776 shares at $13.61 per share.
Get notified when new Form 4 filings are submitted
| $16.28 |
| Discretionary |
| Nov 3, 2025 | PHAT | $7.1K | Sale | 524 | $13.51 | Discretionary |
| Sep 5, 2025 | PHAT | $5.6K | Sale | 461 | $12.09 | Discretionary |
| Jul 16, 2025 | PHAT | $14.1K | Sale | 1,692 | $8.36 | Discretionary |